Javascript must be enabled to continue!
Thymic Development of Beta-Cell Specific Regulatory T Cells in Neonatal NOD Mice
View through CrossRef
Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that involves the destruction of insulin producing β cells found within the pancreatic islets of Langerhans. Recent attention to neonatal thymocyte development has revealed a window during which central tolerance is established in an Autoimmune Regulator (Aire) dependent manner. However, expression of Chromogranin A (ChgA) within the thymus has not been detected; therefore, tolerance to ChgA may be due in part to peripheral dendritic cells (DCs) presenting ChgA to developing thymocytes. The relative contribution of thymically and peripherally derived antigens in the generation of neonatal β cell antigen specific CD4+ regulatory T cells (Tregs) is not well understood. For example, post-translational modification (PTM) of ChgA by fusion with an insulin peptide increases epitope immunogenicity by forming neo-antigens. Pathogenic T cells that are specific for neo-antigens uniquely expressed in the pancreas may escape thymic selection. Therefore, we utilized two experimental designs to test the role of peripheral antigen exposure on neonatal development of β cell specific Tregs. Firstly, we adoptively transferred dendritic cells pulsed with ChgA peptides into BDC2.5 TCR Tg mice and WT NOD mice to study the role of migratory DCs on neonatal development of ChgA Tregs. Secondly, we targeted thymic Langerin+ dendritic cells with anti-Langerin linked to ChgA peptides. In both experimental approaches, we found a robust increase in the ratio and number of ChgA specific Tregs in the presence of the hybrid insulin/chromogranin A peptide (2.5HIP) while also observing an increase in negative selection. The expansion of thymic Tregs was observed in both adult and neonatal mice. Together our data suggests neonatal exposure to PTM peptides enhances thymic development of β cell specific Tregs and may alter T1D pathogenesis.
Disclosure
Y. Lin: None. T. Lee: None. M. Bettini: None. M. Bettini: None.
Title: Thymic Development of Beta-Cell Specific Regulatory T Cells in Neonatal NOD Mice
Description:
Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that involves the destruction of insulin producing β cells found within the pancreatic islets of Langerhans.
Recent attention to neonatal thymocyte development has revealed a window during which central tolerance is established in an Autoimmune Regulator (Aire) dependent manner.
However, expression of Chromogranin A (ChgA) within the thymus has not been detected; therefore, tolerance to ChgA may be due in part to peripheral dendritic cells (DCs) presenting ChgA to developing thymocytes.
The relative contribution of thymically and peripherally derived antigens in the generation of neonatal β cell antigen specific CD4+ regulatory T cells (Tregs) is not well understood.
For example, post-translational modification (PTM) of ChgA by fusion with an insulin peptide increases epitope immunogenicity by forming neo-antigens.
Pathogenic T cells that are specific for neo-antigens uniquely expressed in the pancreas may escape thymic selection.
Therefore, we utilized two experimental designs to test the role of peripheral antigen exposure on neonatal development of β cell specific Tregs.
Firstly, we adoptively transferred dendritic cells pulsed with ChgA peptides into BDC2.
5 TCR Tg mice and WT NOD mice to study the role of migratory DCs on neonatal development of ChgA Tregs.
Secondly, we targeted thymic Langerin+ dendritic cells with anti-Langerin linked to ChgA peptides.
In both experimental approaches, we found a robust increase in the ratio and number of ChgA specific Tregs in the presence of the hybrid insulin/chromogranin A peptide (2.
5HIP) while also observing an increase in negative selection.
The expansion of thymic Tregs was observed in both adult and neonatal mice.
Together our data suggests neonatal exposure to PTM peptides enhances thymic development of β cell specific Tregs and may alter T1D pathogenesis.
Disclosure
Y.
Lin: None.
T.
Lee: None.
M.
Bettini: None.
M.
Bettini: None.
Related Results
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice.
Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice.
Abstract
Intracerebral infection of certain strains of mice with Theiler's virus results in chronic immune-mediated demyelination in spinal cord. We used mouse mutan...
Altered Thymic and Peripheral T-Lymphocyte Repertoire Preceding Onset of Diabetes in NOD Mice
Altered Thymic and Peripheral T-Lymphocyte Repertoire Preceding Onset of Diabetes in NOD Mice
Insulitis occurs by 5 wk of age in all NOD mice. However, diabetes is detectable only after 3–5 mo of age and only in ∼50% of females and 10% of males in our colony. Therefore, it ...
Comprehensive IsomiR sequencing profile of human pancreatic islets and EndoC-βH1 beta-cells
Comprehensive IsomiR sequencing profile of human pancreatic islets and EndoC-βH1 beta-cells
AbstractAims/HypothesisMiRNAs play a crucial role in regulating the islet transcriptome, influencing beta cell functions and pathways. Emerging evidence suggests that during biogen...
Abstract 1776: Exploring anetumab ravtansine in a preclinical model of thymic carcinoma
Abstract 1776: Exploring anetumab ravtansine in a preclinical model of thymic carcinoma
Abstract
Thymic epithelial tumors (TETs) are a group of rare tumors (0.13 per 100,000 persons), comprised of thymomas and thymic carcinoma, arising from the epitheli...
Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...
Replacing murine insulin 1 with human insulin protects NOD mice from diabetes
Replacing murine insulin 1 with human insulin protects NOD mice from diabetes
AbstractType 1, or autoimmune, diabetes is caused by the T-cell mediated destruction of the insulin-producing pancreatic beta cells. Non-obese diabetic (NOD) mice spontaneously dev...
Retropharyngeal Aberrant Thymus
Retropharyngeal Aberrant Thymus
Introduction.
Upper airway obstruction from a retropharyngeal mass requires urgent evaluation. In children, the differential diagnosis includes infection, trauma,...

